Lilly’s Newest Bull Says Near 300% Rally Is Only the Beginning

Eli Lilly's stock price has increased approximately 300 percent since the approval of its first GLP-1 drug over four years ago. The company's market value has exceeded $1 trillion, making it the world's most valuable pharmaceutical company by market capitalization.

Next story